Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Perioperative Therapy, Breast Cancer

Tatiana Prowell

MD

🏢FDA / Johns Hopkins Sidney Kimmel Comprehensive Cancer Center🌐USA

Breast Cancer Scientific Lead, FDA Oncology Center of Excellence

35
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Tatiana Prowell is the breast cancer scientific lead at the FDA Oncology Center of Excellence and drove acceptance of pathologic complete response as a regulatory endpoint for accelerated approval in high risk early breast cancer. She continues practice at Johns Hopkins. Her work has shaped perioperative drug development.

Share:

🧪Research Fields 研究领域

accelerated approval neoadjuvant
pCR endpoint
FDA regulatory
breast cancer drug development
trial design

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Tatiana Prowell 的研究动态

Follow Tatiana Prowell's research updates

留下邮箱,当我们发布与 Tatiana Prowell(FDA / Johns Hopkins Sidney Kimmel Comprehensive Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment